Total Payments
$10,588
2024 Payments
$2,303
Companies
37
Transactions
464
Medicare Patients
2,857
Medicare Billing
$426,984
Payment Breakdown by Category
Food & Beverage$8,639 (81.6%)
Travel$1,491 (14.1%)
Education$257.50 (2.4%)
Consulting$200.00 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,639 | 451 | 81.6% |
| Travel and Lodging | $1,491 | 7 | 14.1% |
| Education | $257.50 | 5 | 2.4% |
| Consulting Fee | $200.00 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,321 | 147 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,359 | 62 | $0 (2024) |
| Olympus Corporation of the Americas | $901.13 | 7 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $806.85 | 43 | $0 (2024) |
| Cook Incorporated | $646.25 | 1 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $522.92 | 18 | $0 (2024) |
| GENZYME CORPORATION | $497.46 | 21 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $405.32 | 17 | $0 (2024) |
| Amgen Inc. | $379.46 | 19 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $373.83 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,303 | 105 | GlaxoSmithKline, LLC. ($449.45) |
| 2023 | $2,034 | 91 | GlaxoSmithKline, LLC. ($432.71) |
| 2022 | $1,979 | 100 | GlaxoSmithKline, LLC. ($362.18) |
| 2021 | $1,675 | 99 | GlaxoSmithKline, LLC. ($610.24) |
| 2020 | $2,128 | 67 | Cook Incorporated ($646.25) |
| 2019 | $468.55 | 2 | Olympus Corporation of the Americas ($468.55) |
All Payment Transactions
464 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Immunology | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Pulmonology | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Immunology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), AIRSUPRA | Education | In-kind items and services | $45.04 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/30/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Immunology | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Pulmonology | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 690 | 955 | $224,660 | $91,300 |
| 2022 | 11 | 671 | 920 | $189,485 | $89,979 |
| 2021 | 12 | 735 | 1,080 | $157,340 | $111,625 |
| 2020 | 12 | 761 | 1,188 | $176,697 | $134,080 |
Total Patients
2,857
Total Services
4,143
Medicare Billing
$426,984
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 101 | 230 | $105,810 | $38,498 | 36.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 135 | 236 | $48,340 | $21,514 | 44.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 79 | 81 | $30,299 | $10,844 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 88 | $12,320 | $7,797 | 63.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $9,520 | $6,293 | 66.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 46 | $4,600 | $2,691 | 58.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 32 | $4,480 | $1,983 | 44.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 55 | 55 | $1,653 | $501.66 | 30.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 21 | 21 | $1,365 | $415.17 | 30.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 54 | 54 | $2,727 | $366.23 | 13.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 32 | 32 | $1,986 | $255.04 | 12.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 24 | 24 | $1,560 | $142.62 | 9.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 115 | 228 | $86,650 | $38,294 | 44.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 139 | 237 | $42,027 | $18,489 | 44.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 73 | 75 | $22,671 | $10,854 | 47.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 83 | $11,620 | $7,725 | 66.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $10,540 | $7,671 | 72.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 60 | $5,750 | $3,717 | 64.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 36 | $4,181 | $1,988 | 47.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 20 | 20 | $1,052 | $364.02 | 34.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 36 | 37 | $980.00 | $325.50 | 33.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 37 | 38 | $1,556 | $247.39 | 15.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 29 | 29 | $1,707 | $221.74 | 13.0% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 14 | 15 | $751.00 | $83.33 | 11.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 127 | 318 | $76,800 | $55,547 | 72.3% |
About Dr. Timothy Keys, M.D
Dr. Timothy Keys, M.D is a Pulmonary Disease healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760471197.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Keys, M.D has received a total of $10,588 in payments from pharmaceutical and medical device companies, with $2,303 received in 2024. These payments were reported across 464 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($8,639).
As a Medicare-enrolled provider, Keys has provided services to 2,857 Medicare beneficiaries, totaling 4,143 services with total Medicare billing of $426,984. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Hospitalist
- Location Lafayette, LA
- Active Since 10/18/2005
- Last Updated 06/28/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1760471197
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,361
- DUPIXENT (Biological) $1,020
- Olympus EBUS Bronchoscopes (Device) $901.13
- NUCALA (Biological) $885.87
- Cook Medical Percutaneous Tracheostomy (Device) $646.25
- TEZSPIRE (Biological) $632.11
- OFEV (Drug) $520.92
- FASENRA (Biological) $419.96
- Adempas (Drug) $373.83
- Prolastin-C Liquid (Biological) $361.39
- ACTHAR (Biological) $337.59
- Arikayce (Drug) $292.96
- STIOLTO RESPIMAT (Drug) $273.01
- OPSUMIT (Drug) $234.22
- BREZTRI (Drug) $194.27
- YUPELRI (Drug) $188.74
- UPTRAVI (Drug) $171.10
- BREZTRI AEROSPHERE (Drug) $148.63
- TYVASO (Drug) $125.92
- Da Vinci Surgical System (Device) $123.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Lafayette
Mr. Walter Brown, Md, MD
Pulmonary Disease — Payments: $12,452
Pulmonary Disease $12,452
Mr. George Guidry, Md, MD
Pulmonary Disease — Payments: $11,149
Pulmonary Disease $11,149
Fadi Malek, M.d. F.c.c.p, M.D. F.C.C.P
Pulmonary Disease — Payments: $9,325
Pulmonary Disease $9,325
Justin Ardoin, M.d, M.D
Pulmonary Disease — Payments: $8,447
Pulmonary Disease $8,447
Richard Fei, M.d. F.c.c.p, M.D. F.C.C.P
Pulmonary Disease — Payments: $5,969
Pulmonary Disease $5,969
Mehboob Kalani, Md, MD
Pulmonary Disease — Payments: $5,488
Pulmonary Disease $5,488